Calliditas Therapeutics AB (CHIX:CALTXS) Current Deferred Taxes Liabilities : kr0 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Calliditas Therapeutics AB Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Calliditas Therapeutics AB's current deferred tax liabilities for the quarter that ended in Mar. 2024 was kr0 Mil.

Calliditas Therapeutics AB Current Deferred Taxes Liabilities Historical Data

The historical data trend for Calliditas Therapeutics AB's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calliditas Therapeutics AB Current Deferred Taxes Liabilities Chart

Calliditas Therapeutics AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Deferred Taxes Liabilities

Get a 7-Day Free Trial

Calliditas Therapeutics AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Calliditas Therapeutics AB Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Calliditas Therapeutics AB's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Calliditas Therapeutics AB (CHIX:CALTXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calliditas Therapeutics AB (CHIX:CALTXs) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

CALT:USA CALTX:Sweden LC8:Germany LC8A:Germany LC8:Germany

Address

Kungsbron 1, D5, Stockholm, SWE, SE-111 22

Website

https://www.calliditas.se

Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.

Calliditas Therapeutics AB (CHIX:CALTXS) Headlines

No Headlines